Effects of extended-release buprenorphine treatment for opioid dependence
Submitted by Edie
- 23 March 2022
In this webinar, findings were reported from the CoLAB qualitative study, which aimed to examine the multiple social, material and temporal effects of extended-release buprenorphine depot (BUP-XR) treatment in clients’ lives, among a group of participants receiving BUP-XR in Australia, and considers the situated potentials of these new opioid agonist treatment technologies.
In particular, the researchers consider how the shift from daily to monthly dosing altered how opioid agonist treatment was experienced, reconfigured participants’ relationship to treatment, and affected the temporal patterns of participants’ lives.
